Published in Cancer Weekly, May 1st, 2012
Non-Small Cell Lung Cancer - Pipeline Review, H1 2012
Global Markets Direct's, 'Non-Small Cell Lung Cancer - Pipeline Review, H1 2012', provides an overview of the Non-Small Cell Lung Cancer therapeutic pipeline. This report provides information on the therapeutic development for Non-Small Cell Lung Cancer, complete with latest updates, and special features on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.